Physician

Charles William Mcmahon, M.D.

According to 2025 Medicare claims, Charles Mcmahon, M.D. (NPI: 1861768053) practices gastroenterology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Jackson, MO. This provider's primary affiliated billing organization is MID AMERICA GASTRO INTESTINAL CONSULTANTS P C (NPI: 1710091228; TIN: 431356738) and primary practice location at 64111-5936.

Mcmahon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 448 traditional Medicare patients, billed 25,644 HCPCS/CPT codes, and received $321,290 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 868 prescription claims across 519 beneficiaries totaling $497,741 in drug costs, led by Stelara (Ustekinumab). Open Payments data shows 41 records totaling $819. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $32,693 to $321,290. Similarly, Part D prescription costs have risen steadily, from $41,035 to $497,741. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$161K$321K2018 Medicare payment: $32,693 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $84,695 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $67,029 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $82,319 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $93,496 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $171,725 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $321,290 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018175348$32,693
2019458870$84,695
2020354714$67,029
20213772,303$82,319
20224034,800$93,496
202342118,788$171,725
202444825,644$321,290

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$249K$498K2015 Drug cost: $41,035 (USD; Tot_Drug_Cst)2016 Drug cost: $70,382 (USD; Tot_Drug_Cst)2017 Drug cost: $26,294 (USD; Tot_Drug_Cst)2018 Drug cost: $14,442 (USD; Tot_Drug_Cst)2019 Drug cost: $22,272 (USD; Tot_Drug_Cst)2020 Drug cost: $47,251 (USD; Tot_Drug_Cst)2021 Drug cost: $54,302 (USD; Tot_Drug_Cst)2022 Drug cost: $53,377 (USD; Tot_Drug_Cst)2023 Drug cost: $339,645 (USD; Tot_Drug_Cst)2024 Drug cost: $497,741 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201528121$41,035
20163393$70,382
20172852$26,294
201876140$14,442
2019166295$22,272
2020157381$47,251
2021309486$54,302
2022357589$53,377
2023395677$339,645
2024519868$497,741

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare137141$199
45380Biopsy of large bowel using a flexible endoscope177178$90
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3647$85
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope9195$62
99231Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes2327$38

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
StelaraUstekinumab14392$382,906
CreonLipase/Protease/Amylase12384$37,419
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates396637$26,494
OmeprazoleOmeprazole1499,747$1,954
Budesonide DrBudesonide16824$1,819

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.41$819ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Charles William Mcmahon, M.D.?

Tedicare shows public-source Medicare data for Charles William Mcmahon, M.D. (NPI 1861768053), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles William Mcmahon, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles William Mcmahon, M.D.?

Charles William Mcmahon, M.D. is linked to MID AMERICA GASTRO INTESTINAL CONSULTANTS P C (billing NPI 1710091228) in the available physician profile data.

Does Charles William Mcmahon, M.D. have Open Payments data?

Charles William Mcmahon, M.D. has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.